Description
Clinical Description
Aliaxin FL is a sterile, resorbable hyaluronic acid dermal filler manufactured by IBSA Derma and included in the Aliaxin® product line. It is classified as a temporary injectable medical device intended for soft tissue augmentation, with specific suitability for dynamic facial areas. The formulation is based on biofermentative, non-animal derived hyaluronic acid processed using proprietary IBSA technologies, resulting in a cohesive gel with controlled viscoelastic properties .
Clinically, Aliaxin FL is primarily indicated for lip augmentation and contour refinement, where elasticity and tissue adaptability are essential. Its rheological profile supports volumisation while allowing natural movement, making it appropriate for areas subject to frequent muscular activity. The product is gradually biodegraded through physiological metabolic pathways and is designed for use exclusively by qualified medical professionals in accordance with the manufacturer’s Instructions for Use (IFU) .
What Aliaxin FL Is Similar To
Aliaxin FL belongs to the category of hyaluronic acid dermal fillers formulated specifically for lip augmentation and fine contour corrections. Products in this category are characterised by moderate elasticity, controlled cohesivity, and an emphasis on natural integration within mobile tissues.
For clinical orientation, Aliaxin FL can be compared to fillers such as Stylage® Special Lips or Restylane® Kysse. Like Aliaxin FL, these products are HA-based and designed to enhance lip volume and definition while maintaining softness and flexibility. Differences between these fillers may include HA concentration, crosslinking methods, and gel rheology, which can influence handling properties, tissue response, and duration of effect.
Within the Aliaxin® range, Aliaxin FL is positioned for applications requiring a balance of firmness and adaptability rather than deep structural volumisation.
This comparison is provided for clinical orientation only and does not imply interchangeability.
Treatment Areas / Indications
Based on available manufacturer and distributor information, Aliaxin FL is indicated for:
– Lips (volume enhancement and contour definition)
Additional treatment areas are not provided by the manufacturer in publicly accessible IFU documentation .
Usage / Administration (IFU-only section)
Administration parameters must strictly follow the manufacturer’s official Instructions for Use.
Injection depth: not provided by manufacturer
Volume per injection point: not provided by manufacturer
Needle gauge: not provided by manufacturer
Frequency / number of sessions: not provided by manufacturer
Aliaxin FL must be administered only by qualified medical professionals trained in injectable aesthetic procedures, under appropriate aseptic conditions, and in compliance with local regulations and the official IFU .
Ingredient List
– Hyaluronic acid (concentration not provided by manufacturer)
– Sodium chloride
– Phosphate buffer
– Water for injections
Lidocaine content: not provided by manufacturer .
Presentation & Longevity
Presentation: 2 × 1 mL prefilled sterile syringes
Packaging: single-use, sterile medical device
Shelf life: not provided by manufacturer
Longevity of aesthetic effect: not provided by manufacturer
Duration of effect may vary depending on patient metabolism, treatment area, injection technique, and individual clinical factors .
Safety Notes / Contraindications
According to standard safety guidance for hyaluronic acid dermal fillers and publicly available summaries:
– Contraindicated in patients with known hypersensitivity to hyaluronic acid or any formulation components
– Should not be used in areas with active infection or inflammation
– Not recommended during pregnancy or breastfeeding unless specifically authorised by the manufacturer
– Caution is advised in patients with autoimmune disorders or a history of severe allergic reactions
Refer to the full IFU for comprehensive safety information .
Regulatory Status
Aliaxin FL is a CE-marked medical device intended for aesthetic use.
Additional regulatory classifications, such as UKCA marking, are not specified in publicly available documentation and should be verified on the product packaging or official IFU .
FAQ
What type of dermal filler is Aliaxin FL?
Aliaxin FL is a hyaluronic acid-based dermal filler designed for temporary soft tissue augmentation. It uses biofermentative, non-animal derived HA and is intended for controlled volumisation in dynamic facial areas such as the lips. The product is gradually resorbed through natural metabolic processes .
Is Aliaxin FL specifically intended for lip treatments?
Yes. Available manufacturer and distributor information identifies the lips as the primary indication for Aliaxin FL. Other treatment areas are not explicitly listed in public IFU summaries and should not be assumed without confirmation from official documentation .
How long do the effects of Aliaxin FL last?
The manufacturer does not specify an exact duration of effect. As with other HA fillers, longevity depends on individual metabolism, injection technique, and lifestyle factors. Clinicians should assess each patient individually and follow IFU guidance .
Does Aliaxin FL contain lidocaine?
Publicly available documentation does not confirm whether Aliaxin FL contains lidocaine or specify a concentration. Practitioners should verify this information directly from the product packaging or official IFU before treatment .
How does Aliaxin FL differ from other lip fillers?
Aliaxin FL is formulated to provide a balance of firmness and flexibility within the Aliaxin® range. Variations between lip fillers typically relate to HA concentration, crosslinking technology, and rheological properties, which influence handling, tissue integration, and clinical outcomes .
